Prof. Robert Ritzel, Division of Endocrinology, Munich and University of Heidelberg, Germany, presents effective treatment simplification for people with T2D using fixed ration combination of iGlarLixi.

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.